Sign inJoin waitlistJoin the waitlist

Edwin Choy

Director of the Sarcoma Program · Mass General Brigham Cancer Institute

Credentials: · · · ·

History

MGH
2005–Present
Harvard Medical School
Present

Medical Oncology
2005–2007
Hematology and Medical Oncology
Brigham and Women's Hospital
2004–2005
Internal Medicine
Massachusetts General Hospital
2000–2003
New York University Grossman School of Medicine
1996–2000
NYU School of Medicine
2000
Yale University
1993

Research

Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi
Cell · 1999 · First of 8 authors · 648 citations
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
The Lancet · 2016 · 588 citations
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
The Lancet Oncology · 2013 · 458 citations

Francis Hornicek
94 papers
GC
Gregory Cote
56 papers · 2 as a fellow
HM
Henry Mankin
50 papers
Petur Nielsen
33 papers
Thomas Delaney
31 papers
Joseph Schwab
26 papers · 13 as a resident
Ivan Chebib
18 papers
Kevin Raskin
17 papers
Suzanne George
15 papers
John Mullen
14 papers
SS
Scott Schuetze
14 papers
Santiago Lozano-Calderon
13 papers

Clinical trials

SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Principal investigator · Completed · Phase 2
Sarcoma Alliance for Research through Collaboration
2015–2016
Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma
Principal investigator · Completed · Phase 1
Massachusetts General Hospital
2013–2025
Bevacizumab/Doxorubicin/Radiation for Sarcoma
Principal investigator · Active not recruiting · Phase 1
Massachusetts General Hospital
2013–2026
Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma
Principal investigator · Completed · Phase 2
Massachusetts General Hospital
2012–2014